Menu
Enrolling by invitation NCT06541821

Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients

Observational Bladder Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: survey evaluation.
Who it may be relevant to
Registry conditions: Bladder Cancer. Basic parameters: 40 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of Physical Activity, Kinesiophobia, and Stoma Compliance in Patients Undergoing Urostomy for Bladder Cancer

Overview

In this study, it is aimed to determine the level of physical activity, to investigate kinesiophobia, to determine compliance with the stoma and to compare with healthy controls in patients with bladder cancer who have undergone urostomy surgery and live with a stoma.

Interventions

  • Other survey evaluation
    assessment of physical activity, fear of movement, and ostomy compliance

Primary outcome measures

  • International Physical Activity Questionnaire Short Form (IPAQ-SF) [Time frame: 10 minutes]
  • Tampa Kinesiophobia Scale [Time frame: 10 minutes]
  • Ostomy Compliance Scale [Time frame: 10 minutes]

Eligibility criteria

Inclusion criteria

  • The patient group will include people between the ages of 40-75 who underwent urostomy surgery and a stoma after being diagnosed with bladder cancer.
  • The control group will include age-matched healthy people with similar age, body weight and height, without a previous history of cancer.

Exclusion criteria

  • Orthotopic surgeries will not be included in the patient group
  • Being under the age of 40,
  • Being diagnosed with lymphedema,
  • Presence of active metastasis,
  • Neurological pathologies that limit voluntary mobility,
  • Orthopedic and cardiovascular pathologies,
  • Having a learning disability or other cognitive or communication impairment.
  • The control group will be excluded if they have any history of cancer.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Selcuk University — Konya

Identifiers

NCT: NCT06541821 · 2024/07.25

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗